Bringing People Together to Defeat Aging
Rejuve’s mission is to create, evaluate and disseminate new technologies for prolonging healthy human life.
To achieve this mission, Rejuve’s novel technological and business architecture combines AI, blockchain technology and tokenomic incentive mechanisms to facilitate the interaction between individuals, clinics, labs and researchers passionate about health and longevity.
There are four main players in Rejuve’s network.
Individual Rejuve Network members contribute their personal lifestyle, medical and biological data to the secure blockchain-based data-stores of the Rejuve Network, receiving Rejuve Points in return.
Clinics that are Rejuve Network members contribute anonymized data about patients undergoing longevity-related therapies (or non-anonymized data with patient content), receiving Rejuve Points in return.
Rejuve Technologies Corp. (Rejuve Tech), the therapeutics-discovery arm of Rejuve, works closely with Rejuve Network, analyzing the data contributed by individuals and clinics, using AI technology delivered via the SingularityNET decentralized blockchain-based framework. The unique Rejuve AI framework incorporates novel deep neural net architectures with probabilistic logical inference and evolutionary pattern recognition implemented in the OpenCog Artificial General Intelligence system.
Rejuve Technologies also works closely with biomedical research labs, to evaluate and refine hypotheses suggested by its AI technology, and to collaboratively define new longevity therapies.
The interests of Rejuve Points holders are managed by a democratically member-operated organization Rejuve Network.
New therapies discovered by Rejuve Tech will initially be offered preferentially to individuals who hold Rejuve Points, and through clinics that hold Rejuve Points. Profits obtained via licensing these new therapies will be shared with Rejuve Points holders, and a portion of the profits will also be used to support longevity research initiatives.
Rejuve Points are initially non-transferrable. However, the technology infrastructure allows them to be made into fully liquid, transferable tokens at any future point, if this is the democratic decision of Rejuve Network members (who are the individual and clinic Rejuve Points holders).
Via its unique tokenomic framework, leveraging the data and energy of its members and the power of its AI technology, Rejuve aims to accelerate progress on one of the most important applications of modern science and technology: to halt and reverse human aging.
The current global healthcare and medical research establishment does not make personalized healthspan extension a top priority.
Instead, our health systems have a narrow focus on individual morbidities and tend to be reactionary in nature rather than forward-looking. The economic and psychological incentives in the medical world today fail to align the interests of researchers, doctors, and patients to share data and find solutions to the disease of aging.
The explosion in the quantity and complexity of experimental data generated by biomedical research is widely recognized. The amount of data produced daily in genomics alone doubles every seven months, and within the next decade genomics will likely generate up to 40 exabytes of data. This creates a bottleneck in the conversion of data into discoveries, and of discoveries into clinical applications. Given the exponentially growing number of scientific publications (global scientific output doubles every nine years), manual knowledge collection and curation has become extraordinarily challenging.
With the imminent arrival of the silver tsunami, a solution is needed now. More people are dying than ever before – over 150,000 every day, of which two-thirds of deaths are related to aging. This dynamic creates all sorts of serious issues for individuals and society across the social and financial spectrum.
Biotech and AI technologies provide the tools needed to solve these problems, but these solutions need to be deployed in appropriate ways; something the current medical establishment does not adequately facilitate. Rejuve aims to solve these broader health extension issues while providing unique benefits to its visionary early-adopters.
The Rejuve Solution
Rejuve believes that biomedical research bridged with AI technology contains the solution to the aging disease problem.
Contemporary clinical and laboratory techniques, aided by AI analytical, simulation and reasoning tools, can make profound progress towards the abolition of human aging in the near-term. Rejuve is ready to lead the way in originating and refining new solutions, as well as using AI to expedite the discovery of new diagnostic tools and anti-aging treatments.
The Rejuve model contains two distinct but coupled entities: Rejuve Technologies Corp. (Rejuve Tech), focused on using AI to leverage data contributed by Rejuve Network members to discover new longevity therapeutics; and Rejuve Network, focused on coordinating the individuals and clinics constituting its membership to exert democratic control over the use of their data and the exploration of longevity therapeutics.
Rejuve Network members contribute personal medical, biological and lifestyle data to the Rejuve Data Commons, which is secured via cryptographic methods, that gives each member visibility into and control over their data. Member clinics contribute anonymized data with patient consent (or non-anonymized data, based on patient preferences). Contributions of data are rewarded with Rejuve Points.
The contributed data is then analyzed by Rejuve Tech’s AI scientists, using the Rejuve Personal Data Lab‘s AI algorithms running on the SingularityNET platform, together with public biomedical datasets and data obtained from Rejuve Tech’s partner labs. Therapies for life extension, age-associated disease or other medical issues are then refined and tested in biological research labs and clinics operating in partnership with Rejuve Tech.
Alongside its in-house AI analytics, Rejuve Tech will also support selected external longevity-AI research projects, funded via the Rejuve Reserve, a pool of resources that will begin relatively limited and may be replenished via profits from licensing Rejuve Tech therapies or from targeted external investments.
Hypotheses will be generated in such critical areas as target discovery for gene therapies and drugs, drug repurposing, and novel forms of therapeutics, driving new discoveries delivered to members through Rejuve clinics and otherwise. Information derived by Rejuve Tech benefits Rejuve Network members with the tools and techniques to extend their healthy lifespans. Members also receive a share of any profits derived from licensing therapies created based on member data, where the degree of compensation to a member is determined based on their Rejuve Points.
In addition to revenue-sharing Rejuve Network members receive numerous other benefits, including a Rejuve personalized longevity analysis to support and enhance decisions of medical professionals, nutritionists, fitness coaches and other experts. Personalized longevity plans are created by AI to leverage expert human knowledge to support Members.
A key principle underlying Rejuve is that individuals should maintain agency over their own data. The same should hold for clinics large or small. To ensure this principle is maintained as the Rejuve ecosystem evolves, while initially Rejuve Network will be centrally coordinated, once the Rejuve ecosystem is in full operation then the Network will be democratically governed via its members.
Once Rejuve Network is independently democratically governed, then it may choose to explore the option of making Rejuve Points liquid tokens, so they can be traded back and forth for other quantities such as fiat currency. At this point, the legal restrictions associated with members in various jurisdictions will need to be respected.